| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ONCT | Oncternal Therapeutics, Inc. | AKER HAZEL M | Legal Counsel | Jul 21, 2020 | Buy | $2.38 | 41,972 | 99,998 | 46,987 | Jul 23, 2020, 05:00 PM | |
| CADX | CADENCE PHARMACEUTICALS INC | AKER HAZEL M | SVP, GC & Secretary | Mar 19, 2014 | Option Exercise | $14.00 | 3,745 | 52,430 | 0 | Mar 21, 2014, 01:20 PM | |
| CADX | CADENCE PHARMACEUTICALS INC | AKER HAZEL M | SVP, GC & Secretary | Dec 16, 2013 | Option Exercise | $3.51 | 13,014 | 45,679 | 16,759 | Dec 18, 2013, 04:22 PM | |
| CADX | CADENCE PHARMACEUTICALS INC | AKER HAZEL M | SVP, GC & Secretary | Dec 16, 2013 | Sale | $8.76 | 13,014 | 114,003 | 3,745 | Dec 18, 2013, 04:22 PM | |
| CADX | CADENCE PHARMACEUTICALS INC | AKER HAZEL M | SVP, GC & Secretary | Nov 15, 2013 | Option Exercise | $3.51 | 52,056 | 182,717 | 55,801 | Nov 18, 2013, 06:36 PM | |
| CADX | CADENCE PHARMACEUTICALS INC | AKER HAZEL M | SVP, GC & Secretary | Nov 15, 2013 | Sale | $7.40 | 52,056 | 385,475 | 29,773 | Nov 18, 2013, 06:36 PM | |
| CADX | CADENCE PHARMACEUTICALS INC | AKER HAZEL M | SVP, GC & Secretary | Jul 22, 2013 | Option Exercise | $3.51 | 6,507 | 22,840 | 10,252 | Jul 23, 2013, 06:59 PM | |
| CADX | CADENCE PHARMACEUTICALS INC | AKER HAZEL M | SVP, GC & Secretary | Jul 22, 2013 | Sale | $7.81 | 6,507 | 50,820 | 3,745 | Jul 23, 2013, 06:59 PM | |
| CADX | CADENCE PHARMACEUTICALS INC | AKER HAZEL M | SVP, GC & Secretary | Jul 15, 2013 | Sale | $7.34 | 6,508 | 47,780 | 3,745 | Jul 17, 2013, 04:23 PM | |
| CADX | CADENCE PHARMACEUTICALS INC | AKER HAZEL M | SVP, GC & Secretary | Jul 15, 2013 | Option Exercise | $3.51 | 6,508 | 22,843 | 10,253 | Jul 17, 2013, 04:23 PM | |
| CADX | CADENCE PHARMACEUTICALS INC | AKER HAZEL M | SVP, GC & Secretary | Nov 21, 2011 | Sale | $4.16 | 10,000 | 41,621 | 3,745 | Nov 22, 2011, 06:23 PM |
Menu